70results about How to "Indicators are normal" patented technology

The invention discloses fermented mixed fruit and vegetable juice beverages and a preparation method thereof; the preparation method comprises the steps: mainly taking a papaya and carrot mixed fruit and vegetable juice as a fermentation raw material, inoculating with a lactobacillus plantarum DMDL9010 (with the preservation number of CGMCC NO.5172) activation solution according to the volume percentage of 6%-8%, fermenting for 12 h-22 h at the temperature of 28 DEG C-40 DEG C, and thus obtaining the two fermented mixed fruit and vegetable juice beverages. The obtained fermented mixed fruit and vegetable juice beverages allow lactic acid bacteria fermentation and processing of fruits and vegetables to be combined together, belong to natural additive-free beverages, and have suitable taste; the preparation method has the advantages of simple process, low cost, convenience in operation, and large market potential; moreover, the mixed fruit and vegetable juice beverages have a certain function of adjusting human body intestinal health, break up a traditional lactic acid bacteria beverage processing mode, and have important industrial value.

The invention provides a traditional Chinese medicine composition for treating cardiac neurosis. The traditional Chinese medicine composition comprises the following components in parts by weight:18-22 parts of Astragalus root, 12-18 parts of radix codonopsitis, 9-15 parts of Atractylis ovata, 9-18 parts of poria with hostwood, 5-7 parts of polygala root, 7-11 parts of semen zizyphi spinosae, 7-11 parts of longan aril, 7-11 parts of Angelica sinensis, 5-7 parts of baked licorice root, and 12-18 parts of Chinese date. Compared with the prior art, the traditional Chinese medicine composition is directed towards internal pathogenic factors of cardiac neurosis, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a Chinese patent drug for treating infantile diarrhea. The Chinese patent drug comprises, by weight, 5 to 7 parts of monkshood, 8 to 12 parts of tangshen, 8 to 12 parts of deep fried atractylodes, 8 to 12 parts of blast-fried ginger, 5 to 7 parts of medicinal evodia fruit, 8 to 12 parts of Chinese yam, 8 to 12 parts of hyacinth bean, 8 to 12 parts of malaytea scurfpea fruit, 5 to 7 parts of Chinese magnoliavine and 5 to 7 parts of liquorice root. Compared with the prior art, the Chinese patent drug provided by the invention is directed at inherent pathogenic factors of infantile diarrhea, carries out treatment based on syndrome differentiation and has the advantages of a fast curative effect, low cost, no toxic and side effects, a substantial effect and capacity of treating both manifestation and root cause of infantile diarrhea.

The invention provides a Chinese medicinal composition for treating dilated cardiomyopathy. The Chinese medicinal composition comprises the following components in part by weight: 5 to 7 parts of ginseng, 28 to 32 parts of astragalus, 12 to 18 parts of aconite, 12 to 18 parts of large-head atractylodes rhizome, 12 to 18 parts of tuckahoe, 12 to 18 parts of umbellate pore fungus, 9 to 15 parts of cassia twig, 12 to 18 parts of red-rooted salvia root, 28 to 32 parts of motherwort herb, 12 to 18 parts of pepper weed seed, 9 to 15 parts of lily-turf and 5 to 7 parts of Chinese magnoliavine fruit. Compared with the prior art, the Chinese medicinal composition is used for treating dilated cardiomyopathy aiming at internal pathogenic factors according to syndrome differentiation, is quick in curative effect, low in cost and obvious in effect, does not have toxic or side effect, and addresses both the symptoms and root causes.

The purpose of the present invention is to provide a Hugan products and their preparation methods, as described including chrysanthemum, dandelion, wolfberry, cassia seed, Angelica dahurica and schisandrin, carried out by a special combination of natural herbs, effective prevention, and treatment to improve liver dysfunction, such as the role of disease, and its preparation method is simple, stable process conditions suitable for the scale of chemical production.

The invention provides a traditional Chinese medicine preparation for curing dilated cardiomyopathy. The traditional Chinese medicine preparation for curing dilated cardiomyopathy includes, by weight, 12-18 of pilose asiabell roots, 9-15 of dwarf lilyturf roots, 5-7 of Chinese magnoliavine fruit, 7-11 of angelica, 7-11 of Sichuan lovage rhizomes, 9-15 of rehmannia roots, 9-15 of red peony roots, 9-15 of wild jujube seeds, 12-18 of the roots of red-rooted salvia, 18-22 of milkvetch roots and 7-11 of honey-fried licorice roots. Compared with the prior art, the preparation aims to inner pathogenic factor of the dilated cardiomyopathy, symptom is diagnosed, therapy is implemented, the curative effect is quick, the cost is low, no toxic side effect exists, the effect is significant and both principal and secondary aspect of the disease can be treated.

The invention provides a traditional Chinese medicine for treating the renal tuberculosis. The traditional Chinese medicine comprises the following components, by weight, 7-11 parts of lily, 7-11 parts of Radix Ophiopogonis, 7-11 parts of Radix Scrophulariae, 7-11 parts of unprepared rehmannia root, 7-11 parts of white peony root, 5-7 parts of Radix Platycodonis, 7-11 parts of Bulbus Fritillaria, 7-11 parts of turtle shell, 7-11 parts of Rhizoma Anemarrhenae, 7-11 parts of Artemisia carvifolia, 9-15 parts of Cortex Moutan, 9-15 parts of Japanese Thistle Herb, 28-32 parts of Cogongrass rhizome, 7-11 parts of Radix Stemonae, and 5-7 parts of ural licorice root tip. Compared with the prior art, the traditional Chinese medicine has the advantages of syndrome differentiation treatment against the internal pathogenic factors of the renal tuberculosis, rapid curative effect, low cost, no toxic side effects, substantial effects, and simultaneous treatment and principal and subordinate symptoms.

The invention provides a traditional Chinese medicine composition for treating liver-channel-dampness-heat type vulvar eczema. The traditional Chinese medicine composition comprises, by weight, 5 to 7 parts of gentian, 9 to 15 parts of cape jasmine fruit, 7 to 11 parts of root of large-flowered skullcap, 12 to 18 parts of plantain seed, 7 to 11 parts of akebia stem, 9 to 15 parts of oriental waterplantain rhizome, 9 to 15 parts of unprocessed rehmannia root, 9 to 15 parts of Chinese angelica, 5 to 7 parts of licorice, 5 to 7 parts of Chinese thorowax root, 9 to 15 parts of coix seed and 12 to 18 parts of broom cypress fruit. Compared with the prior art, the traditional Chinese medicine composition provided by the invention is directed at the internal pathogenic factors of liver-channel-dampness-heat type vulvar eczema, carries out symptomatic treatment and has the advantages of a fast curative effect, low cost, no toxic and side effects, a substantial effect and capacity of treating both symptoms and root causes.

The invention provides a Chinese patent drug for curing vomit. The Chinese patent drug is composed of the following components by weight: 7 to 11 parts of raw rhubarb, 7 to 11 parts of immature bitter orange, 5 to 7 parts of mangnolia officinalis, 18 to 22 parts of fructus cannabis, 9 to 15 parts of almond, and 8 to 12 parts of radix paeoniae alba. Compared with the prior art, the Chinese patent drug treats the vomit based on syndrome differentiation and internal pathogenic factors thereof, has a quick curative effect and low cost, has no toxic and side effect, has an obvious effect, and treats both symptoms and root causes.

The invention provides a formula of a traditional Chinese medicine for treating cardiac neurosis. The traditional Chinese medicine comprises the following components in parts by weight: 7-11 parts of radix rehmanniae, 7-11 parts of dwarf lilyturf root, 7-11 parts of radix asparagi, 7-11 parts of figwort, 12-18 parts of radix salviae miltiorrhizae, 7-11 parts of Angelica sinensis, 7-11 parts of phellodendron bark, and 7-11 parts of rhizoma anemarrhenae. Compared with the prior art, the traditional Chinese medicine prepared according to the formula is directed towards internal pathogenic factors of cardiac neurosis, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a formula of a traditional Chinese medicine for treating bronchiectasis. The traditional Chinese medicine comprises the following components in parts by weight: 8-12 parts of root bark of white mulberry, 9-15 parts of cortex lycii radicis, 8-12 parts of Baikal skullcap root, 5-7 parts of gentian, 12-18 parts of clam shell, 5-7 parts of natural indigo, 9-15 parts of Eclipta alba, 9-15 parts of radix rehmanniae, 28-32 parts of cogongrass rhizome, 9-15 parts of radix cirsii jeponici, 9-15 parts of field thistle, and 5-7 parts of licorice root. Compared with the prior art, the traditional Chinese medicine prepared according to the formula is directed towards internal pathogenic factors of bronchiectasis, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a traditional Chinese medicine preparation for treating bronchiectasis. The traditional Chinese medicine preparation comprises the following components in parts by weight: 28-32 parts of reed rhizome, 12-18 parts of Chinese waxgourd seed, 9-15 parts of semen persicae, 12-18 parts of semen coicis, 5-7 parts of radix platycodi, 2-4 parts of goldthread root, 9-15 parts of thunberg fritillary bulb, 8-12 parts of tuber pinellia, and 5-7 parts of licorice root. Compared with the prior art, the traditional Chinese medicine preparation is directed towards internal pathogenic factors of bronchiectasis, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a Traditional Chinese medicine for treating chronic rheumatic heart disease. The Chinese patent medicine comprises the following components in parts by weight: 9-15 parts of cassia twig, 7-11 parts of semen persicae, 5-7 parts of safflower, 7-11 parts of hemlock parsley, 9-15 parts of red paeonia, 7-11 parts of Angelica sinensis, 12-18 parts of radix salviae miltiorrhizae, 12-18 parts of radix clematidis, 9-15 parts of corydalis tuber, and 7-11 parts of baked licorice root. Compared with the prior art, the traditional Chinese medicine is directed towards internal pathogenic factors of chronic rheumatic heart disease, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a Chinese patent medicine used for treating yin-deficiency-caused-fire-excess type insomnia during menstruation. The Chinese patent medicine comprises, by weight, 8 to 12 parts of Dangshen, 8 to 12 parts of figwort root, 8 to 12 parts of red sage root, 8 to 12 parts of poria with hostwood, 4 to 6 parts of polygala root, 5 to 7 parts of Chinese magnoliavine fruit, 8 to 12 parts of Chinese angelica, 8 to 12 parts of asparagus tuber, 8 to 12 parts of tuber of dwarf lilyturf, 7 to 11 parts of spine date seed, 12 to 18 parts of unprocessed rehmannia root and 8 to 12 parts of arborvitae seed. Compared with the prior art, the Chinese patent medicine provided by the invention is directed at the internal pathogenic factors of yin-deficiency-caused-fire-excess type insomnia during menstruation, carries out symptomatic treatment and has the advantages of a fast curative effect, low cost, no toxic and side effects, a substantial effect and capacity of treating both symptoms and root causes.

The invention provides a formula of a traditional Chinese medicine containing whitish honey for treating constipation. The medicine comprises the following components in parts by weight: 9-15 parts of whitish honey, 18-22 parts of Astragalus root, 9-15 parts of codonopsis pilosula, 7-11 pars of pericarpium citri reticulatae, 18-22 parts of fructus cannabis, and 12-18 parts of atractylis ovata. Compared with the prior art, the traditional Chinese medicine prepared according to the formula is directed towards internal pathogenic factors of constipation, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides traditional Chinese medicine for treating anaphylactoid purpura. The traditional Chinese medicine comprises the following components in parts by weight: 28-32 parts of gypsum, 12-18 parts of rehmannia root, 9-15 parts of radix scrophulariae, 7-11 parts of bamboo leaves, 9-15 parts of rhizoma anemarrhenae, 9-15 parts of common peony root, 12-18 parts of cortex moutan, 12-18 parts of fructus forsythia, 2-4 parts of rhizoma coptidis, 12-18 parts of baical skullcap root, 12-18 parts of sinkiang arnebia root and 9-15 parts of sophora flower. Compared with the prior art, the traditional Chinese medicine is capable of treating internal pathogenic factors of anaphylactoid purpura according to different symptoms and treating both symptoms and root causes, and is quick in curative effect, low in cost, free of toxic or side effects and remarkable in effect.

The invention provides a Chinese patent drug for treatment of enterobiasis in external and internal administration. The Chinese patent drug comprises the following components in part by weight: 8-12 parts of stone-like omphalia, 8-12 parts of areca nut, 8-12 parts of azedarach, 5-7 parts of elecampane, 5-7 parts of capillary artemisia, 5-7 parts of liquorice root, 8-12 parts of radix sophorae flavescentis, 4-6 parts of fructus cnidii and 2-4 parts of spina gleditsiae. Compared with the prior art, the Chinese patent drug is used for syndrome differentiation treatment aiming at the internal pathogenic factors of the enterobiasis, has the advantages of quick curative effect, low cost, no toxic side effects and remarkable effect, and is endowed with the function for treatment focusing on relieving both the secondary and primary symptoms.

The invention provides a traditional Chinese medicament for treating dilated cardiomyopathy, which comprises the following components in part by weight: 12 to 18 parts of codonopsis pilosula, 9 to 15 parts of largehead atractylodes rhizome, 9 to 15 parts of poria cocos, 7 to 11 parts of rehmannia glutinosa, 7 to 11 parts of angelica, 7 to 11 parts of radix paeoniae alba, 7 to 11 parts of paeonia veitchii, 7 to 11 parts of ramulus cinnamomi, 4 to 6 parts of astragalus mongholicus, 12 to 18 parts of salvia miltiorrhiza, 7 to 11 parts of turmeric root-tuber, and 7 to 11 parts of radix glycyrrhizae preparata. Compared with the prior art, the traditional Chinese medicament, at the aim of the internal pathogenic factors of the dilated cardiomyopathy, performs treatment on the base of the syndrome differentiation, has a fast effect, is ow in cost, has no toxin and side effects, has an obvious effect and, treats both the symptoms and causes.

The invention provides a traditional Chinese medicinal composition for treating neonatal erysipelas, which comprises the following components by weight part: 5 to 7 parts of lonicera japonica, 5 to 7 parts of fructus forsythia, 5 to 7 parts of radix scutellariae, 8 to 12 parts of radix isatidis, 12 to 18 parts of cornu bubali, 5 to 7 parts of radix rehmanniae, 5 to 7 parts of radix scrophulariae, 5 to 7 parts of lithospermum, 5 to 7 parts of rhizoma acori graminei, 5 to 7 parts of cortex moutan, 5 to 7 parts of red paeony roots and 2 to 4 parts of licorice roots northwest origin. Compared with the prior art, the traditional Chinese medicinal composition provided by the invention can be used for dialectically treating the neonatal erysipelas by aiming at internal pathogenic factors thereof, and has the advantages of fast treatment effect, low cost, no toxic and side effects, remarkable effect and treatment of both symptoms and root causes.

The invention provides a Chinese patent medicine for treating constipation. The medicine contains the following components in parts by weight: 7-11 parts of raw rhubarb, 7-11 parts of fruit of immature citron, 5-7 parts of magnolia bark, 18-22 parts of fructus cannabis, 9-15 parts of apricot kernel, and 8-12 parts of radix paeoniae alba. Compared with the prior art, the Chinese patent medicine is directed towards internal pathogenic factors of constipation, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention provides a traditional Chinese medicine for treating pyelonephritis. The traditional Chinese medicine comprises, by weight, 7 to 11 parts of Polygonum aviculare, 7 to 11 parts of lilac pink herb, 28 to 32 parts of plantain seed, 5 to 7 parts of akebia stem, 28 to 32 parts of talc, 7 to 11 parts of cape jasmine, 7 to 11 parts of Chinese rhubarb, 2 to 4 parts of common rush and 2 to 4 parts of licorice. Compared with the prior art, the traditional Chinese medicine provided by the invention is directed at the internal pathogenic factors of pyelonephritis, carries out symptomatic treatment and has the advantages of a fast curative effect, low cost, no toxic and side effects, a substantial effect and capacity of treating both symptoms and root causes.

The invention provides a Chinese patent medicine for treating bronchiectasis. The Chinese patent medicine comprises the following components in parts by weight: 9-15 parts of radix rehmanniae, 9-15 parts of lily root, 9-15 parts of dwarf lilyturf root, 12-18 parts of radix paeoniae alba, 5-7 parts of Angelica sinensis, 8-12 parts of thunberg fritillary bulb, 9-15 parts of figwort, 12-18 parts of cogongrass rhizome, 2-4 parts of rhizoma picrorhizae, 8-12 parts of madder, and 5-7 parts of raw licorice root. Compared with the prior art, the Chinese patent medicine is directed towards internal pathogenic factors of bronchiectasis, treats the disease by differentiating symptom, is quick in curative effect, low in cost, and prominent in effect, has no toxic or side effect, and treats the root cause and symptoms.

The invention relates to hawthorn liver-protective tea, which is a health-caring tea bag including following components as raw materials: hawthorns, gynostemma pentaphylla, mulberry fruits, salviae miltiorrhizae, white peony roots, dandelion, astragalus membranaceus, cordyceps sinensis, ganoderma lucidum and strigose hydrangea juvenile leaves. The tea is convenient to use, can protect liver, has effects of clearing heat and removing toxin, moistening intestine and relaxing bowel, beautifying face and dispelling spots and preventing hypertension, hyperglycemia and hyperlipidemia, can achieve an object of protecting liver when being employed, and is especially suitable for patients who often stay up late, drink wine, are suffered from poxes and are suffered from hypertension.